{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:40:49Z","timestamp":1795081249423,"version":"4.10.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA241758"],"award-info":[{"award-number":["R01 CA241758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCT04815876"],"award-info":[{"award-number":["NCT04815876"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.eururo.2023.12.015","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T03:51:51Z","timestamp":1704945111000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":207,"title":["Transperineal Versus Transrectal Magnetic Resonance Imaging\u2013targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-5542","authenticated-orcid":false,"given":"Jim C.","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Assel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad E.","family":"Allaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behfar","family":"Ehdaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Ristau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misop","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Pavlovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith J.","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilajit D.","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiten D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Shoag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2023.12.015_b0005","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jama.2015.6036","article-title":"Trends in management for patients with localized prostate cancer, 1990\u20132013","volume":"314","author":"Cooperberg","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2023.12.015_b0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.juro.2016.11.081","article-title":"Indications, utilization and complications following prostate biopsy: New York State analysis","volume":"197","author":"Halpern","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-5347(05)67453-8","article-title":"Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy","volume":"164","author":"Lindert","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","article-title":"An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy","volume":"198","author":"Liss","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.urology.2019.12.023","article-title":"Risk factors for infection after prostate biopsy in the United States","volume":"138","author":"Shoag","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2023.12.015_b0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0040","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"Force","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2023.12.015_b0045","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","article-title":"Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care","volume":"187","author":"Taylor","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12879-017-2470-1","article-title":"Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial","volume":"17","author":"Zembower","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eururo.2023.12.015_b0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2019.06.011","article-title":"Time to adapt our practice? The European Commission has restricted the use of fluoroquinolones since March 2019","volume":"76","author":"Bonkat","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00345-016-1985-1","article-title":"Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis","volume":"35","author":"Pepdjonovic","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1442-2042.2009.02269.x","article-title":"Simple and effective local anesthesia for transperineal extended prostate biopsy: application to three-dimensional 26-core biopsy","volume":"16","author":"Kubo","year":"2009","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0070","doi-asserted-by":"crossref","first-page":"e071191","DOI":"10.1136\/bmjopen-2022-071191","article-title":"Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectious complications","volume":"13","author":"Hu","year":"2023","journal-title":"BMJ Open"},{"issue":"76","key":"10.1016\/j.eururo.2023.12.015_b0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2","volume":"2019","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1740774517746610","article-title":"Just-in-time consent: the ethical case for an alternative to traditional informed consent in randomized trials comparing an experimental intervention with usual care","volume":"15","author":"Vickers","year":"2018","journal-title":"Clin Trials"},{"key":"10.1016\/j.eururo.2023.12.015_b0085","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.12.015_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d7894","article-title":"Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study","volume":"344","author":"Rosario","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2023.12.015_b0095","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajem.2005.07.009","article-title":"The minimum clinically significant difference in patient-assigned numeric scores for pain","volume":"23","author":"Kendrick","year":"2005","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.eururo.2023.12.015_b0100","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ajem.2019.158489","article-title":"How much change in pain score does really matter to patients?","volume":"38","author":"Bahreini","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.eururo.2023.12.015_b0105","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/JU.0000000000002118","article-title":"Testing-related health impact of transrectal and transperineal prostate biopsy as assessed by health utilities","volume":"206","author":"Shankar","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0110","doi-asserted-by":"crossref","unstructured":"Mian BM, Feustel PJ, Aziz A, et al. Complications following transrectal and transperineal prostate biopsy: results of the ProBE-PC randomized clinical trial. J Urol. In press. https:\/\/doi.org\/10.1097\/JU.0000000000003788.","DOI":"10.1097\/JU.0000000000003788"},{"key":"10.1016\/j.eururo.2023.12.015_b0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bju.15935","article-title":"Findings from an international survey of urology trainee experience with prostate biopsy","volume":"131","author":"Brant","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2023.12.015_b0120","doi-asserted-by":"crossref","first-page":"ofw265","DOI":"10.1093\/ofid\/ofw265","article-title":"Infection-related hospital admissions after prostate biopsy in United States men","volume":"4","author":"Evans","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.eururo.2023.12.015_b0125","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects: May 12, 2016. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics."},{"key":"10.1016\/j.eururo.2023.12.015_b0130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2023.12.015_b0135","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jnci\/djac066","article-title":"Grade migration of prostate cancer in the United States during the last decade","volume":"114","author":"Borregales","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2023.12.015_b0140","unstructured":"Centers for Disease Control and Prevention. Core elements of outpatient antibiotic stewardship. https:\/\/www.cdc.gov\/antibiotic-use\/core-elements\/outpatient.html."},{"key":"10.1016\/j.eururo.2023.12.015_b0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.juro.2018.03.078","article-title":"Targeted antimicrobial prophylaxis does not always prevent sepsis after transrectal prostate biopsy","volume":"200","author":"Jiang","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.juro.2015.03.126","article-title":"A statewide intervention to reduce hospitalizations after prostate biopsy","volume":"194","author":"Womble","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0155","unstructured":"Centers for Disease Control and Prevention Antibiotic Resistance and Patient Safety Portal. Fluoroquinolone-resistant E. coli. https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/fluoroquinolone-resistant-ecoli?hai-select-resistance-by-state=hai32&hai-select-resistance-by-state-and-region=hai32."},{"key":"10.1016\/j.eururo.2023.12.015_b0160","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.juro.2013.08.088","article-title":"The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance","volume":"191","author":"Ehdaie","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2023.12.015_b0165","unstructured":"PCORI. Comparing two types of prostate biopsy. https:\/\/www.pcori.org\/research-results\/2020\/comparing-two-types-prostate-biopsy."},{"key":"10.1016\/j.eururo.2023.12.015_b0170","doi-asserted-by":"crossref","first-page":"djv324","DOI":"10.1093\/jnci\/djv324","article-title":"Predicting low accrual in the National Cancer Institute\u2019s Cooperative Group clinical trials","volume":"108","author":"Bennette","year":"2016","journal-title":"J Natl Cancer Inst"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823033420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283823033420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:14:39Z","timestamp":1778742879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283823033420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0302283823033420"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2023.12.015","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transperineal Versus Transrectal Magnetic Resonance Imaging\u2013targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2023.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}